COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem

Ann Hepatol. 2021 Sep-Oct:24:100525. doi: 10.1016/j.aohep.2021.100525.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Jaundice* / diagnosis
  • Jaundice* / etiology
  • Liver
  • SARS-CoV-2
  • Thrombocytopenia* / diagnosis

Substances

  • COVID-19 Vaccines